Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Cysteamine therapy for children with nephropathic cystinosis.

Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA.

N Engl J Med. 1987 Apr 16;316(16):971-7.

PMID:
3550461
2.

Improved renal function in children with cystinosis treated with cysteamine.

Markello TC, Bernardini IM, Gahl WA.

N Engl J Med. 1993 Apr 22;328(16):1157-62.

3.

NIH conference. Cystinosis: progress in a prototypic disease.

Gahl WA, Thoene JG, Schneider JA, O'Regan S, Kaiser-Kupfer MI, Kuwabara T.

Ann Intern Med. 1988 Oct 1;109(7):557-69. Review.

PMID:
3048161
4.

Effects of cysteamine therapy in nephropathic cystinosis.

Yudkoff M, Foreman JW, Segal S.

N Engl J Med. 1981 Jan 15;304(3):141-5.

PMID:
7442733
5.

[Cysteamine in the treatment of cystinosis in children. In vitro and in vivo studies].

Louis JJ, Guibaud P, Dumoulin R, Parchoux B, Zabot MT, Bureau J, Baltassat P, Frederich A, Larbre F.

Pediatrie. 1984 Dec;39(8):619-33. French.

PMID:
6535971
7.

[Treatment of cystinosis using cysteamine].

Broyer M, Tete MJ.

Ann Pediatr (Paris). 1990 Feb;37(2):91-3. French.

PMID:
2321906
9.

Adverse reactions to oral cysteamine use in nephropathic cystinosis.

Corden BJ, Schulman JD, Schneider JA, Thoene JG.

Dev Pharmacol Ther. 1981;3(1):25-30.

PMID:
7307866
10.

Report of a Brazilian multicenter study on nephropathic cystinosis.

Vaisbich MH, Koch VH.

Nephron Clin Pract. 2010;114(1):c12-8. doi: 10.1159/000245065. Epub 2009 Oct 9.

PMID:
19816039
11.

Intravenous cysteamine therapy for nephropathic cystinosis.

Gahl WA, Ingelfinger J, Mohan P, Bernardini I, Hyman PE, Tangerman A.

Pediatr Res. 1995 Oct;38(4):579-84.

PMID:
8559613
12.

Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.

Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA.

Medicine (Baltimore). 2005 May;84(3):137-46.

13.

Long-term treatment of cystinosis in children with twice-daily cysteamine.

Dohil R, Gangoiti JA, Cabrera BL, Fidler M, Schneider JA, Barshop BA.

J Pediatr. 2010 May;156(5):823-7. doi: 10.1016/j.jpeds.2009.11.059. Epub 2010 Feb 6.

PMID:
20138296
14.

Pharmacological treatment of nephropathic cystinosis with cysteamine.

Kleta R, Gahl WA.

Expert Opin Pharmacother. 2004 Nov;5(11):2255-62. Review.

PMID:
15500372
15.

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.

Bouazza N, Tréluyer JM, Ottolenghi C, Urien S, Deschenes G, Ricquier D, Niaudet P, Chadefaux-Vekemans B.

Orphanet J Rare Dis. 2011 Dec 23;6:86. doi: 10.1186/1750-1172-6-86.

16.

Nephropathic cystinosis: effect of long-term cysteamine therapy.

Proesmans W, Baten E, Hoogmartens J, Bruyneel P.

Clin Nephrol. 1987 Jun;27(6):309-12.

PMID:
3608256
17.

Treatment of cystinosis with cysteamine. A pilot study determining dose and form of application.

Bergonzi E, Herren A, Lavanchy P, Bühlmann C, Wyss SR, Lüthy C, Oetliker O.

Helv Paediatr Acta. 1981 Nov;36(5):437-43.

PMID:
7031022
18.

Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.

Nesterova G, Williams C, Bernardini I, Gahl WA.

Pediatr Nephrol. 2015 Jun;30(6):945-51. doi: 10.1007/s00467-014-3018-x. Epub 2014 Dec 20.

PMID:
25526929
19.

Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis.

Schneider JA, Schlesselman JJ, Mendoza SA, Orloff S, Thoene JG, Kroll WA, Godfrey AD, Schulman JD.

N Engl J Med. 1979 Apr 5;300(14):756-9.

PMID:
370586
20.

Supplemental Content

Support Center